In a breast cancer biology setting, another interesting finding is related to the fact that P-cadherin, like C/EBPβ, is not mutated in breast tumours, but its overexpression has been widely described in a subset of aggressive breast cancers [5]. This evidence concerns the gene CDH3 and breast cancer.